Digital Obturators in Maxillectomy Cases

July 29, 2024 updated by: Eman Nasr, Tanta University

Evaluation of Digital Versus Conventional Roofless Obturators in Partial Maxillectomy Cases

Using Digital approach to treat patients with maxillofacial defects without surgical intervention

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Evaluating digital dental and maxillofacial obturators to artifitially close maxillofacial defects in paients with oral cancer and patients with mucormycosis fungal post covid infection.

Craeting Digitized database for all patients included in the study.

Recording casses with post covid infection in specific period.

Study Type

Interventional

Enrollment (Actual)

7

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gharbeya
      • Tanta, Gharbeya, Egypt
        • Eman Nasr

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

-

All participants in this study will be selected according to the following criteria:

  • Patients with maxillary defects Class I and class II Aramany Classification with completely healed tissues.
  • Patients' age ranging from 20 to 70 years old.
  • Nearly intact mandibular arch.

Exclusion Criteria:

-

Participants with the following criteria will be excluded from the study:

  • Physical or mental instability.
  • Completely edentulous patients.
  • Patients presenting allergy to materials being used.
  • Patients lacking compliance to maintain acceptable oral hygiene.
  • Patients taking radiotherapy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Device Feasibility
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: digital obturator
new approach to create device
special maxillofacial device to close hollow defects
Experimental: conventional obturator
old approach to create device
special maxillofacial device to close hollow defects

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of hypernasality in speech
Time Frame: one month
physiologic parameter
one month
Evaluation of masseter muscle muscle
Time Frame: three months
physiologic parameter
three months
Evaluation of Patient Quality of Life
Time Frame: six months
questionnaire
six months
Evaluation of retention
Time Frame: 1 day (at time of device insertion)
descriptive by KP scale
1 day (at time of device insertion)
Obturator misfit
Time Frame: 1 day (at time of device delivery)
descriptive by Digital software
1 day (at time of device delivery)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: ali al shaikh, professor, Tanta University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 21, 2021

Primary Completion (Actual)

May 1, 2022

Study Completion (Actual)

January 7, 2024

Study Registration Dates

First Submitted

April 15, 2024

First Submitted That Met QC Criteria

July 29, 2024

First Posted (Actual)

July 30, 2024

Study Record Updates

Last Update Posted (Actual)

July 30, 2024

Last Update Submitted That Met QC Criteria

July 29, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RP08-21\4

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Device Malfunction

Clinical Trials on obturator

Subscribe